Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatment
- 31 July 1994
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (1), 3-13
- https://doi.org/10.1016/0002-9343(94)90042-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Low‐dose high‐frequency enzyme replacement therapy for very young children with severe Gaucher diseaseBritish Journal of Haematology, 1993
- Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 monthsBlood, 1993
- Treatment of Gaucher's DiseaseNew England Journal of Medicine, 1993
- Abnormal neutrophil chemotaxis in Gaucher diseaseBritish Journal of Haematology, 1993
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Enzyme Augmentation in Moderate to Life-Threatening Gaucher DiseasePediatric Research, 1992
- Hematologic improvement in a patient with gaucher disease on long‐term enzyme replacement therapy: Evidence for decreased splenic sequestration and improved red blood cell survivalAmerican Journal of Hematology, 1991
- Enzyme replacement therapy for Gaucher diseaseBlood, 1991
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVELThe Lancet, 1989